1. Home
  2. ABR vs MLTX Comparison

ABR vs MLTX Comparison

Compare ABR & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$5.03

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.53

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
MLTX
Founded
2003
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
ABR
MLTX
Price
$5.03
$15.53
Analyst Decision
Hold
Buy
Analyst Count
5
12
Target Price
$9.90
$27.50
AVG Volume (30 Days)
4.1M
1.3M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.73
$5.95
52 Week High
$12.58
$62.75

Technical Indicators

Market Signals
Indicator
ABR
MLTX
Relative Strength Index (RSI) 45.42 36.32
Support Level $4.94 $14.84
Resistance Level $5.45 $19.24
Average True Range (ATR) 0.15 0.73
MACD -0.01 -0.07
Stochastic Oscillator 25.64 13.78

Price Performance

Historical Comparison
ABR
MLTX

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: